Evaluation of the Safety of Folate Receptor-Targeted Boron Carrier in Boron Neutron Capture Therapy (BNCT) for Malignant Gliomas Using CED Administration

Knowing how to accumulate boron into the tumor cells is a crucial aspect of boron neutron capture therapy (BNCT), which can be targeted at the cellular level, and the development of novel boron agents other than BPA, which is used in clinical practice, is urgently needed [...]

Bibliografski detalji

Glavni autori:	Kohei Tsujino, Hideki Kashiwagi, Ryo Kayama, Yoshiki Fujikawa, Yusuke Fukuo, Ryo Hiramatsu, Naosuke Nonoguchi, Takushi Takata, Hiroki Tanaka, Minoru Suzuki, Naonori Hu, Masahiko Wanibuchi, Kei Nakai, Kai Nishimura, Hiroyuki Nakamura, Shinji Kawabata
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2024-03-01
Serija:	Proceedings
Teme:	boron neutron capture therapy gliomas convection-enhanced delivery (CED) folate receptor
Online pristup:	https://www.mdpi.com/2504-3900/100/1/15
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!